Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1999-04-08
2000-06-27
Krass, Frederick
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514874, 514951, 514952, 514958, 424 43, 424 45, 424 46, 424489, A01N 2502, A61K 914
Patent
active
060807628
ABSTRACT:
The present invention relates to formulations and methods for pulmonary and nasal administration of raloxifene.
REFERENCES:
patent: 4133814 (1979-01-01), Jones et al.
patent: 4418068 (1983-11-01), Jones
patent: 5441965 (1995-08-01), Sall et al.
patent: 5484798 (1996-01-01), Bryant et al.
patent: 5641790 (1997-06-01), Draper
patent: 5952513 (1999-09-01), Palkowitz
Allen Darrel LaVern
Leiter Paula Ann
Tielking Richard Leon
Wolff Ronald Keith
Eli Lilly and Company
Krass Frederick
Voy Gilbert T.
LandOfFree
Pulmonary and nasal delivery of raloxifene does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pulmonary and nasal delivery of raloxifene, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pulmonary and nasal delivery of raloxifene will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1785060